Active Ingredient History

  • Now
Dacetuzumab is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.   Wikipedia

More Chemistry
dacetuzumab | hus2c6 | hu s2c6 | sgn 40 | sgn-40 | sgn40 cpd


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue